By Sy Mukherjee; Fortune ~ Jul 14, 2016
Companies continued to raise prices significantly in Q1.
Big pharma’s widespread habit of regularly raising the price of their medicines has galvanized public outrage and given 2016 political candidates a convenient piñata.
But new data suggest that, so far, the outrage is still more bark than bite.

